SelectQuote, Inc. (NYSE: SLQT) announced the launch of a new franchise‑based distribution channel, SelectQuote Local, designed to complement its existing telephonic insurance platform. The channel will allow franchise owners to sell the company’s senior health and life insurance products through local representatives while leveraging SelectQuote’s technology, marketing, and carrier relationships.
The new model gives consumers the option to meet with a local representative while still accessing the same affordable, simple insurance shopping experience that has driven SelectQuote’s growth. Bill Grant, COO, said, "We see SelectQuote Local as a natural extension of our existing SelectQuote business. We believe SelectQuote Local creates an opportunity to extend our reach to more consumers, namely those who wish to do business with someone in their local market."
SelectQuote’s leadership highlighted that the launch aligns with its broader strategy to diversify revenue sources and strengthen its insurance distribution network. Ryan Clement, CFO, noted, "From a financial perspective, we think SelectQuote Local provides an exciting and cash‑efficient opportunity to leverage our proven technology and carrier platform to drive increased scale to our insurance distribution business. We expect the SelectQuote Local model to require a low level of capital investment from the Company and, over time, to create a recurring royalty stream providing compelling cash‑on‑cash returns for shareholders."
Financial context underscores the strategic importance of the new channel. In Q4 FY2024, SelectQuote reported revenue of $307.2 million, a 39% year‑over‑year increase from $221.8 million in Q4 FY2023, and a net loss of $31.0 million versus a $47.8 million loss in the prior year. Adjusted EBITDA turned positive at $14.4 million, up from a loss of $5.8 million in Q4 FY2023. The company’s healthcare services platform, SelectRx, grew membership 17% to 113,483 in Q2 FY2026, and the franchise model is expected to generate a recurring royalty stream with minimal capital investment, further supporting the company’s transformation toward a comprehensive healthcare services platform.
Analysts have mixed views on the announcement. A consensus of “Hold” ratings is reported, with price targets averaging $2.92, while some analysts have upgraded to a “Buy” consensus. The launch is viewed as a tailwind that diversifies revenue and reduces business risk, complementing the strong growth seen in SelectRx and the company’s broader diversification strategy.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.